Association between Glutathione S-Transferase M1 and Ti Polymorphisms and Colorectal Cancer Risk in Patients from Kazakhstan

被引:3
|
作者
Zhunussova, Gulnur [1 ]
Zhunusbekova, Benazir [1 ]
Djansugurova, Leyla [1 ]
机构
[1] Inst Gen Genet & Cytol, Mol Genet Lab, Alma Ata 050060, Kazakhstan
关键词
colorectal cancer; GSTM1; GS77'1; deletion polymorphism; Kazakhstan population; GENETIC POLYMORPHISMS; GSTT1; POLYMORPHISMS; CIGARETTE-SMOKING; GSTM1; SUSCEPTIBILITY; CARCINOGENS; POPULATION; CYP1A1; GSTP1; T1;
D O I
10.7754/Clin.Lab.2014.140803
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Colorectal cancer (CRC) is one of the most common malignancies worldwide and the incidence is increasing in developed as well as developing countries including Kazakhstan. Glutathione S-transferases (GSTs) are considered to be cancer susceptibility genes as they play a role in the detoxification of carcinogenic species. In this case-control study the influence of GSTMI and GSTTI polymorphisms on CRC risk in Kazakhstan population were evaluated. Methods: Blood samples were collected from patients diagnosed with rectal or colon cancer (300 individuals) as well as a control cohort of healthy volunteers (300 individuals), taking into account the age, gender, ethnicity, and smoking habits of the CRC patients. Deletion polymorphisms were genotyped employing a multiplex PCR amplification method. Association between polymorphisms and CRC susceptibility risk was calculated using multivariate analysis and logistic regression for odd ratio (OR). Results: The homozygous GSTMI null genotype was associated with significantly increased risk of CRC (OR = 2.01, 95% Cl = 1.45 - 2.79, p = 0.0001) while the homozygous GSST1 null genotype was not associated with the risk of developing CRC (OR = 1.10, 95% CI = 0.78 - 1.55, p = 0.001), but the heterozygous genotype correlated with CRC susceptibility (OR = 1.98, 95% CI = 1.30 - 3.00, p = 0.001). Also, separate analyses of each of the main ethnic groups (Kazakh and Russian) showed a strong association of GSTMI null genotype with CRC risk (for Kazakhs OR = 2.36, 95% Cl = 1.35- 4.10, p = 0.006 and for Russians OR = 1.84, 95% Cl = 1.17 - 2.89, p = 0.003). The CRC risk of GSTM1 null genotype in smokers was considerably higher (OR = 3.37, 95% Cl = 1.78 - 6.38, p = 0.0007). The combination of the GSTM1 and GSTTI null genotypes in combined mixed population of Kazakhstan showed a trend to increasing the risk of developing CRC (OR = 1.60, 95% CI = 1.00 - 2.56), but it was not statistically significant. Conclusions: In conclusion, the results of this case-control study for sporadic cases of CRC show that GSTMI deletion polymorphisms can have predictive value for susceptibility to CRC (OR = 2.01, p = 0.0001) for the mixed population from Kazakhstan and for both main ethnic groups (Kazakhs and Russians (OR = 2.36 and OR = 1.84, respectively)).
引用
收藏
页码:161 / 168
页数:8
相关论文
共 50 条
  • [1] Association of glutathione S-transferase M1 polymorphisms in the colorectal cancer risk: A meta-analysis
    Huang, Min
    Zeng, Yan
    Zhao, Fen
    Huang, Ying
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (01) : 176 - 183
  • [2] Association of glutathione S-transferase M1 polymorphisms and lung cancer risk in a Chinese population
    Liu, Dazhong
    Wang, Fei
    Wang, Qiushi
    Guo, Xiaotong
    Xu, Hao
    Wang, Wei
    Zhang, Linyou
    [J]. CLINICA CHIMICA ACTA, 2012, 414 : 188 - 190
  • [3] Glutathione s-transferase M1 and Ti genetic polymorphisms in Iranian patients with glaucoma
    Safa, Fatemeh Kazemi
    Shahsavari, Gholamreza
    Abyaneh, Reza Zare
    [J]. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2014, 17 (05) : 332 - 336
  • [4] Glutathione S-transferase M1 polymorphism and colorectal cancer risk in Chinese population
    Teng, Zan
    Wang, Lei
    Zhang, Jingdong
    Cai, Shuang
    Liu, Yunpeng
    [J]. TUMOR BIOLOGY, 2014, 35 (03) : 2117 - 2121
  • [5] Glutathione S-transferase P1, M1, T1 polymorphisms in patients with colorectal cancer
    Farker, K.
    Merkel, U.
    Wedding, U.
    Gruca, D.
    Hoeffken, K.
    Hippius, M.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 380 - 380
  • [6] Association between Glutathione S-Transferase T1, M1, and P1 Genotypes and the Risk of Colorectal Cancer
    Cong, Ning
    Liu, Lisheng
    Xie, Ying
    Shao, Wenbo
    Song, Jinlong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (11) : 1488 - 1492
  • [7] Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers
    Jeong, HJ
    Kim, HJ
    Seo, IY
    Kim, HJ
    Oh, GJ
    Chae, SC
    Lim, JS
    Chung, HT
    Kim, JJ
    [J]. CANCER LETTERS, 2003, 202 (02) : 193 - 199
  • [8] Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson's disease: A meta-analysis
    Wang, Tengfei
    Wang, Bin
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 338 (1-2) : 65 - 70
  • [9] Glutathione S-transferase M1 polymorphism and the risk of lung cancer
    Mohr, LC
    Rodgers, JK
    Silvestri, GA
    [J]. ANTICANCER RESEARCH, 2003, 23 (3A) : 2111 - 2124
  • [10] Association between glutathione S-transferase A1, M1 and T1 polymorphisms and hypertension
    Oniki, Kentaro
    Hori, Masaharu
    Takata, Keiji
    Yokoyama, Tomoko
    Mihara, Shuichi
    Marubayashi, Toru
    Nakagawa, Kazuko
    [J]. PHARMACOGENETICS AND GENOMICS, 2008, 18 (03): : 275 - 277